Matches in Wikidata for { <http://www.wikidata.org/entity/Q87882625> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q87882625 description "article scientifique publié en 2018" @default.
- Q87882625 description "artículu científicu espublizáu n'abril de 2018" @default.
- Q87882625 description "im April 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87882625 description "scientific article published on 01 April 2018" @default.
- Q87882625 description "wetenschappelijk artikel" @default.
- Q87882625 description "наукова стаття, опублікована у квітні 2018" @default.
- Q87882625 name "Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists" @default.
- Q87882625 name "Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists" @default.
- Q87882625 type Item @default.
- Q87882625 label "Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists" @default.
- Q87882625 label "Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists" @default.
- Q87882625 prefLabel "Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists" @default.
- Q87882625 prefLabel "Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists" @default.
- Q87882625 P1433 Q87882625-405FEFE6-8507-4CE5-BC16-EF5A3E138F13 @default.
- Q87882625 P1476 Q87882625-A93E32F1-9245-4B88-8624-323CFEDE1E6D @default.
- Q87882625 P2093 Q87882625-C3DE603D-B462-4CC9-9F97-2C423F7F7AAE @default.
- Q87882625 P2093 Q87882625-DFDF0060-5A2D-45F9-BB21-1E2B9FF84D91 @default.
- Q87882625 P2093 Q87882625-E21AD20A-6F24-4734-892E-64FF1029DFF5 @default.
- Q87882625 P304 Q87882625-91E9D538-2AF4-4106-9AEC-82928F86A41A @default.
- Q87882625 P31 Q87882625-AA61E529-DE14-491B-8A26-0FB4A9D0CF5A @default.
- Q87882625 P356 Q87882625-0AE18036-EAFB-43DA-A1C4-0B54A8199F48 @default.
- Q87882625 P433 Q87882625-69244FA5-18B7-458E-B5C8-558654621EAF @default.
- Q87882625 P478 Q87882625-644D71CC-1ED3-41F1-8679-FB2F879325F2 @default.
- Q87882625 P50 Q87882625-F805C00B-055D-4E7D-8374-5F6CD2788DD3 @default.
- Q87882625 P577 Q87882625-8949CEAE-2C14-4284-811B-B6B36F599F38 @default.
- Q87882625 P698 Q87882625-E73FF9DD-1ED7-4412-875F-9EFC7CAAAD2D @default.
- Q87882625 P356 FBP.0000000000000377 @default.
- Q87882625 P698 29481424 @default.
- Q87882625 P1433 Q15754239 @default.
- Q87882625 P1476 "Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists" @default.
- Q87882625 P2093 "Catherine M Cahill" @default.
- Q87882625 P2093 "Mary C Olmstead" @default.
- Q87882625 P2093 "Patrick Grenier" @default.
- Q87882625 P304 "241-254" @default.
- Q87882625 P31 Q13442814 @default.
- Q87882625 P356 "10.1097/FBP.0000000000000377" @default.
- Q87882625 P433 "2 and 3-Spec Issue" @default.
- Q87882625 P478 "29" @default.
- Q87882625 P50 Q87882623 @default.
- Q87882625 P577 "2018-04-01T00:00:00Z" @default.
- Q87882625 P698 "29481424" @default.